National Institute of Nursing Research, National Institutes of Health, Bethesda, MD; School of Nursing and Health Studies, Georgetown University, Washington, DC.
William F. Connell School of Nursing, Boston College, Chestnut Hill, MA.
Nurs Outlook. 2021 May-Jun;69(3):471-488. doi: 10.1016/j.outlook.2020.12.006. Epub 2021 Jan 22.
As genomic science moves beyond government-academic collaborations into routine healthcare operations, nursing's holistic philosophy and evidence-based practice approach positions nurses as leaders to advance genomics and precision health care in routine patient care.
To examine the status of and identify gaps for U.S. genomic nursing health care policy and precision health clinical practice implementation.
We conducted a scoping review and policy priorities analysis to clarify key genomic policy concepts and definitions, and to examine trends and utilization of health care quality benchmarking used in precision health.
Genomic nursing health care policy is an emerging area. Educating and training the nursing workforce to achieve full dissemination and integration of precision health into clinical practice remains an ongoing challenge. Use of health care quality measurement principles and federal benchmarking performance evaluation criteria for precision health implementation are not developed.
Nine recommendations were formed with calls to action across nursing practice workforce and education, nursing research, and health care policy arenas.
To advance genomic nursing health care policy, it is imperative to develop genomic performance measurement tools for clinicians, purchasers, regulators and policymakers and to adequately prepare the nursing workforce.
随着基因组科学从政府-学术合作扩展到常规医疗保健业务，护理的整体哲学和循证实践方法使护士能够在常规患者护理中引领推进基因组学和精准医疗保健。
检查美国基因组护理医疗政策和精准健康临床实践实施的现状并确定差距。
我们进行了范围审查和政策重点分析，以阐明关键的基因组政策概念和定义，并研究精准健康中使用的医疗保健质量基准测试的趋势和利用情况。
基因组护理医疗政策是一个新兴领域。教育和培训护理人员队伍，以实现精准健康的全面传播和整合到临床实践中仍然是一个持续的挑战。尚未制定用于精准健康实施的医疗保健质量衡量原则和联邦基准绩效评估标准。
在护理实践工作队伍和教育、护理研究以及医疗保健政策领域形成了九条建议，并呼吁采取行动。
为了推进基因组护理医疗政策，必须为临床医生、购买者、监管者和政策制定者制定基因组绩效衡量工具，并充分准备护理人员队伍。
